All-Cause Mortality and Gastrointestinal Adverse Effects in Adults With Type 2 Diabetes on Glucagon-Like Peptide-1 Receptor Agonists vs Sodium–Glucose Cotransporter-2 Inhibitors

Authors:
  • TQThabet Qapaja
    Thabet Qapaja
  • OHOsama Hamid
    Osama Hamid
  • GKGizem Kaya
    Gizem Kaya
  • RARashid Abdel-Razeq
    Rashid Abdel-Razeq
  • DADina Alayan
    Dina Alayan
  • MAMohammed Abu-Rumaileh
    Mohammed Abu-Rumaileh
  • ALAnthony Lembo
    Anthony Lembo
  • SNSteven Nissen
    Steven Nissen

Abstract
No abstract available
Funding Information
  • Abbott Pharmaceuticals

This publication has 24 references indexed in Scilit: